United States Digital Ovulation Test Kits Market Gears Up for a Surge, Projecting a Valuation of US$ 185 Million with a 9.1% CAGR by 2033-FMI Study

Over the course of the projection period, the united states digital ovulation test kits market is expected to rise at a significant pace of 9.1%, from US$ 77.4 million in 2023 to US$ 185.0 million in 2033.

Key manufacturers in the United States are undertaking various initiatives such as awareness campaigns, medication maintenance, and online education programs to promote women’s health and raise awareness about conditions like PCOS and PCOD. The adoption of digital ovulation test kits is on the rise due to their ease of use and accurate results displayed on digital screens.

Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-13241

Manufacturers are introducing new features, such as detecting multiple fertility hormones, to meet the demand for advanced digital ovulation tests. However, the availability of alternatives, high prices of digital kits, and occasional product recalls pose challenges to the market’s growth. Nonetheless, ongoing product development efforts by companies offering technologically advanced features are reshaping the United States digital ovulation test kit market and driving demand.

The introduction of affordable digital kits by local manufacturers may further boost the market in the future. Branded test kits are projected to be the top-selling product in the digital ovulation test kits market, accounting for over 83% of the revenue by 2031. This is attributed to the increasing availability of branded test kits through e-commerce, which has driven their demand.

The top two players currently cover more than 72% of the market share in the United States Institutional sales, are driven by increasing fertility awareness and the growing demand for ovulation testing in hospitals. These are expected to be the leading distribution channel, generating a revenue of US$ 95.1 million by 2031.

Branded test kits dominate the United States digital ovulation test kits market, holding a market share of nearly 85.20% in 2022. The leading players in the market are actively promoting their branded test kits through various e-commerce platforms, driving their high demand.

Institutional sales, on the other hand, contribute a significant revenue share of over 54.21% in the market. This is primarily due to the widespread availability of digital ovulation test kits in hospital pharmacies and fertility centers, ensuring easy access for consumers and a higher likelihood of finding quality products.

Unlock exclusive insights with our expert analysts:
https://www.futuremarketinsights.com/ask-question/rep-gb-13241

Competitive Landscape:

Swiss Precision Diagnostics GmbH, Church & Dwight Co. Inc., Prestige Consumer Healthcare, Inc., Hilin Life Products., Fairhaven Health LLC, Geratherm Medical AG, Piramal Enterprises Ltd, NecLife, and others are some market participants identified in the global Ovulation Test Kit market.

• Crown Laboratories, a prominent, fully integrated global skincare company and a Hildred Capital Management LLC portfolio company, and L Catterton, the world’s leading consumer-focused private equity firm, announced the acquisition of StriVectin in August 2021. The transaction, subject to regulatory clearances and other standard closing conditions, is scheduled to be completed by mid-September 2021.
• In June 2021, bioMérieux announced the sale of a detailed diagnostics’ REVEAL Rapid AST system in Europe, strengthening the market for rapid testing kits.
• Through the Real Talk with Conceiving Hood Campaign, actress Jordana Brewster collaborated with Clearblue in April 2021 to raise awareness about the difficulty of conceiving and women’s fertility.

Key Companies:

• Swiss Precision Diagnostics GmbH
• Church & Dwight Co., Inc.
• Gregory Pharmaceutical Holdings, Inc.
• Sugentech, Inc.
• iXensor Co. Ltd
• Samplytics Technologies Private Limited
• Bio-AMD

Market Segmentation:

By Product:

• Branded Test Kits
• Private Label Test Kits

By Distribution Channel:

• Institutional Sales
• Hospital Pharmacies
• Gynaecology Clinics
• IVF Clinics
• Maternity Care Centers
• Retail Sales
• Retail Pharmacies
• Drug Stores
• Hypermarkets & Supermarkets
• Online Sales

Unlock Tailored Insights: Customize Your Report for Maximum Impact :
https://www.futuremarketinsights.com/customization-available/rep-gb-13241

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube